PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

Psychiatric Bulletin (2007) 31: 94-96. doi: 10.1192/pb.bp.106.012955
© 2007 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in PB
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleakley, S.
Right arrow Articles by Taylor, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bleakley, S.
Right arrow Articles by Taylor, D.

Which antipsychotics would mental health professionals take themselves?

Stephen Bleakley, Senior Pharmacist

South London and the Maudsley NHS Foundation Trust

Olubanke Olofinjana, Senior Pharmacist

South London and the Maudsley NHS Foundation Trust

David Taylor, Chief Pharmacist

South London and the Maudsley NHS Foundation Trust and Honorary Senior Lecturer, Institute of Psychiatry, Pharmacy Department, Maudsley Hospital, Denmark Hill, London SE5 8AZ, email: David.Taylor{at}slam.nhs.uk

Declaration of interest

D.T. has received research funding and/or honoraria from Bristol-Myers Squibb, Sanofi-Synthelabo, Lundbeck, AstraZeneca and Novartis.

AIMS AND METHOD

Many studies report prescribing preferences for antipsychotics but few have examined what professionals would choose for themselves if they were diagnosed with schizophrenia. We asked 188 nurses, pharmacists and doctors which antipsychotic they would prefer to be prescribed.

RESULTS

Risperidone (n=49, 26.1%), olanzapine (n=49, 26.1%) and aripiprazole (n=35, 18.6%) were the most popular choices.

CLINICAL IMPLICATIONS

Professionals’ choice was in line with the latest evidence on comparative effectiveness of atypical antipsychotics and therefore might be a sensitive indicator of the most effective antipsychotic.


Related articles in PB:

Dominance of second-generation antipsychotics - time for reflection?
Benjamin R. Underwood
PB 2007 31: 233. [Full Text]  

Antipsychotics preferred by mental health professionals
Mark Taylor
PB 2007 31: 272. [Full Text]  

Antipsychotics preferred by mental health professionals
Peter Lepping
PB 2007 31: 272. [Full Text]  





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2007 The Royal College of Psychiatrists.